SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-349142
Filing Date
2021-12-06
Accepted
2021-12-06 17:22:02
Documents
17
Period of Report
2021-12-01
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d257552d8k.htm   iXBRL 8-K 28086
2 EX-1.1 d257552dex11.htm EX-1.1 227037
3 EX-5.1 d257552dex51.htm EX-5.1 6250
4 EX-99.1 d257552dex991.htm EX-99.1 8997
8 GRAPHIC g257552g1206102836962.jpg GRAPHIC 2943
9 GRAPHIC g257552g33s26.jpg GRAPHIC 10666
  Complete submission text file 0001193125-21-349142.txt   479574

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA meip-20211201.xsd EX-101.SCH 2894
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE meip-20211201_lab.xml EX-101.LAB 18138
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE meip-20211201_pre.xml EX-101.PRE 11409
10 EXTRACTED XBRL INSTANCE DOCUMENT d257552d8k_htm.xml XML 3348
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-50484 | Film No.: 211473942
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences